Connect with the Tandem Mobi system

The Tandem Mobi system is now powered by Control-IQ+ technology—the only predictive algorithm with AutoBolus. The best Tandem algorithm ever pairs with Dexcom G7 CGM Systems to predict and help prevent highs and lows for more time in range.¹

The pump is indicated for use in persons 2 years of age and greater.
Dexcom G7 15 Day is for use in adults 18+

Freedom to choose the Tandem Mobi System

Control-IQ+ Technology

Control-IQ+ offers unique and enhanced features for more targeted control. It’s the only predictive algorithm with AutoBolus—which includes a 30-minute prediction and automatically adjusts insulin delivery every 5-minutes to help protect from highs and lows.¹

The pump is indicated for use in persons 2 years of age and greater.

Sleep Activity Setting

Only Tandem pumps have a dedicated Sleep Activity, which is designed to help protect from overnight lows and morning highs with fewer disruptions from alerts and alarms.

AutoBolus

AutoBolus* is designed to help prevent highs and cover missed meal boluses.

*If glucose values are predicted to be above 180 mg/dL (or 10.0 mmol/L), Control-IQ+ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL (or 6.1 mmol/L) and delivers 60% of that value.

Trusted partners in diabetes management

Dexcom and Tandem have created life-changing³ diabetes management solutions with over a decade of collaboration.

Man wearing G7 and Tandem Mobi eating food

Dexcom G7 and Dexcom G7 15 Day

Delay 1st and Urgent Low Soon features that help protect from severe hypos and DKA^2-4
No fingersticks^† from day 1
The ability to connect to multiple devices^‡ and health apps simultaneously
Urgent Low Soon alert,^§ notifies you of a severe low up to 20 minutes before it happens

†Fingersticks required for diabetes treatment decision if symptoms or expectations do not match readings. §Audible and visual notification of predictive alert at 55 mg/dL within 20 minutes. G7 15 Day is only for adults 18+

Tandem Mobi

The world's smallest durable AID system⁵
Wearability like never before^||–wear it (on body),^¶ clip it (to clothes), slip it (in pocket)
Pump button for checking the pump status lights and to give a Quick Bolus
Control-IQ+ uses Dexcom G7 glucose values to predict and help prevent from highs and lows, providing continuous automation¹
Create up to six Personal Profiles based on insulin needs

||Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin. ¶Adhesive sleeve sold separately.

Meet Dexcom G7 CGM Systems

With Dexcom G7 and Dexcom G7 15 Day, you have the option to choose the insulin pump that works best for you. Glucose readings are sent to your smartphone or Dexcom receiver—without fingersticks.^†

†Fingersticks required for diabetes treatment decision if symptoms or expectations do not match readings.
Dexcom G7 15 Day is for use in adults 18+  

Get started now

Do you have questions about the Tandem Mobi system?

Our experts are here to help.

‡Smart device sold separately. To view a list of compatible devices, visit https://www.dexcom.com/compatibility.

1 Kudva YC, et al. N Engl J Med. 2025;392(18):1801-12. 2 Dexcom, Data on File, 2025. 3 Puhr S,et al. Diabetes Technol Ther. 2019;21(4):155-8. 4 Acciaroli G, et al. J Diabetes Sci Technol. 2022;16(3):677-82. 5 As of Feb. 2024. Data on file, Tandem Diabetes Care.

BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

RX ONLY. The Tandem Mobi insulin pump with interoperable technology (the pump) and Control -IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. Tandem Mobi system: The Tandem Mobi insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.

Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.

WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control -IQ+ to operate safely.

Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

MAT-3553